New Onset Diabetes in Pancreatic Adenocarcinoma Does Not Correlate With Molecular Subtype
As continued interest in NOD and PDAC mounts, we are the first to examine if NOD may be associated with molecular subtypes and outcomes. Further investigation into the underlying pathophysiology of the NOD group is still needed.
Authors
- Sandra Zarmer
- Joseph F. Kearney (ORCID: https://orcid.org/0000-0002-7258-7301)
- Arthi Hariharan
- Michael O. Meyers (ORCID: https://orcid.org/0000-0003-4787-4752)
- Hong Jin Kim (ORCID: https://orcid.org/0000-0002-2382-1827)
- Jen Jen Yeh (ORCID: https://orcid.org/0000-0003-2542-6211)
- Hannah E. Trembath (ORCID: https://orcid.org/0000-0001-8655-3551)
- Ian McCabe
- Michelle E. LaBella
- Ryan T. Zhao
- Mariaelena Nabors
Institutions
- University of North Carolina at Chapel Hill (US)
Publication Details
- Journal
- Journal of Surgical Oncology
- Published
- 2024-12-22
- DOI
- https://doi.org/10.1002/jso.28044
- Citations
- 3
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- National Cancer Institute